CYTOKINETICS CCO exercises options, sells 15K shares
CYTOKINETICS INC executive Andrew Callos reported an option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CYTOKINETICS INC executive Andrew Callos reported an option exercise and share sale. On 2026-06-01, he exercised non-qualified stock options to acquire 15,000 shares of Common Stock at $23.26 per share, then sold 15,000 shares in an open-market sale at $74.08 per share.
Following these transactions, Callos directly held 58,555 shares of Common Stock. The exercised stock options were part of an award that vests over four years from grant, with 25% vesting after one year and the remainder vesting monthly over the next 36 months, subject to continued employment.
Insider Trade Summary 10b5-1
Exercise and Sale: 15,000 shares ($762K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Callos Andrew
Role
EVP, Chief Commercial Officer
Sold
15,000 shs ($1.11M)
Approx. gross sale proceeds
$1.11M
Approx. exercise cost
$349K
Approx. pre-tax spread
$762K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $23.26 | $349K |
| Sale | Common Stock | 15,000 | $74.08 | $1.11M |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 39,000 contracts (Direct);
Common Stock — 58,555 shares (Direct)
Footnotes (1)
- F1. Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer.
Key Figures
Shares sold: 15,000 shares
Sale price: $74.08 per share
Shares exercised: 15,000 shares
+4 more
7 metrics
Shares sold
15,000 shares
Common Stock open-market sale on June 1, 2026
Sale price
$74.08 per share
Price for 15,000 Common Stock shares sold
Shares exercised
15,000 shares
Common Stock acquired via option exercise
Exercise price
$23.26 per share
Non-qualified stock option exercise price
Shares after transactions
58,555 shares
Direct Common Stock holdings after June 1, 2026
Options remaining
39,000 options
Total derivative options reported following transaction
Option expiration
March 31, 2031
Expiration date of exercised option grant
Key Terms
Non-Qualified Stock Option, open-market sale, derivative security, vest over 4 years
4 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (Right to Buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vest over 4 years financial
"Stock options will vest over 4 years from the date of the grant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did CYTK executive Andrew Callos report?
Andrew Callos reported exercising stock options for 15,000 CYTK shares and selling 15,000 shares in an open-market transaction. The exercise price was $23.26 per share, and the sale price was $74.08 per share, all on June 1, 2026.
What stock options did CYTK executive Andrew Callos exercise in this Form 4?
He exercised non-qualified stock options covering 15,000 shares of CYTOKINETICS Common Stock at an exercise price of $23.26 per share. These options were part of a grant that vests over four years, subject to his continued employment with the company.
How do Andrew Callos’s CYTK stock options vest over time?
His stock options vest over four years from the grant date. One-quarter of the underlying shares vest on the first anniversary of the grant, with the remaining three-quarters vesting monthly over the subsequent 36 months, contingent on continued employment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
